- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia? ; volume:19 ; number:1 ; day:12 ; month:11 ; year:2019 ; pages:1-8 ; date:12.2019
BMC cancer ; 19, Heft 1 (12.11.2019), 1-8, 12.2019
- Creator
-
Acik, Didar Yanardag
Bankir, Mehmet
Baylan, Filiz Alkan
Aygun, Bilal
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6325-6
- URN
-
urn:nbn:de:101:1-2020030921534436739493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Acik, Didar Yanardag
- Bankir, Mehmet
- Baylan, Filiz Alkan
- Aygun, Bilal
- SpringerLink (Online service)
Other Objects (12)
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia